| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 134.266 | 221.156 | 383.675 | 222.873 | 109.152 | 344.081 | 561.938 | 205.685 | 226.763 |
| Total Income - EUR | 0 | 134.267 | 221.439 | 383.687 | 222.884 | 109.157 | 346.163 | 561.942 | 205.690 | 226.331 |
| Total Expenses - EUR | 0 | 97.841 | 144.158 | 315.828 | 211.492 | 61.779 | 142.760 | 369.908 | 126.950 | 136.047 |
| Gross Profit/Loss - EUR | 0 | 36.426 | 77.281 | 67.859 | 11.393 | 47.378 | 203.403 | 192.034 | 78.740 | 90.284 |
| Net Profit/Loss - EUR | 0 | 31.326 | 75.081 | 64.022 | 9.164 | 46.286 | 200.415 | 186.527 | 77.354 | 84.321 |
| Employees | 0 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Doicemed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 1.241 | 6.812 | 6.057 | 5.885 | 7.455 | 11.973 | 17.510 | 15.473 |
| Current Assets | 45 | 107.691 | 186.254 | 196.897 | 101.187 | 52.688 | 246.726 | 306.759 | 148.299 | 194.882 |
| Inventories | 0 | 22.197 | 33.730 | 23.932 | 21.776 | 9.568 | 46.936 | 59.349 | 64.476 | 70.496 |
| Receivables | 0 | 41.869 | 48.300 | 49.334 | 33.028 | 34.677 | 146.316 | 231.321 | 53.255 | 74.205 |
| Cash | 45 | 43.625 | 104.225 | 123.630 | 46.382 | 8.442 | 53.475 | 16.088 | 30.569 | 50.181 |
| Shareholders Funds | 45 | 31.370 | 75.141 | 95.492 | 42.726 | 43.152 | 197.358 | 183.461 | 94.796 | 81.281 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 76.320 | 112.354 | 108.216 | 64.663 | 15.563 | 56.963 | 135.412 | 71.153 | 129.213 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Doicemed Srl